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Abstract
Background: Increased left ventricular (LV) torsion has been observed in patients with manifest familial
hypertrophic cardiomyopathy (HCM), and is thought to be caused by subendocardial dysfunction. We hypothesize
that increased LV torsion is already present in healthy mutation carriers with normal wall thickness.
Methods: Seventeen carriers with an LV wall thickness <10 mm, and seventeen age and gender matched controls
had cardiovascular magnetic resonance (CMR) cine imaging and tissue tagging. LV volumes and mass were
calculated from the cine images. LV torsion, torsion rate, endocardial circumferential strain and torsion-to-
endocardial-circumferential-shortening (TECS) ratio, which reflects the transmural distribution in contractile function,
were determined using tissue tagging.
Results: LV volumes, mass and circumferential strain were comparable between groups, whereas LV ejection
fraction, torsion and TECS-ratio were increased in carriers compared to controls (63 ± 3% vs. 60 ± 3%, p = 0.04,
10.1 ± 2.5° vs. 7.7 ± 1.2°, p = 0.001, and 0.52 ± 0.14°/% vs. 0.42 ± 0.10°/%, p = 0.02, respectively).
Conclusions: Carriers with normal wall thickness display increased LV torsion and TECS-ratio with respect to
controls, which might be due to subendocardial myocardial dysfunction. As similar abnormalities are observed in
patients with manifest HCM, the changes in healthy carriers may be target for clinical intervention to delay or
prevent the onset of hypertrophy.
Introduction
Hypertrophic cardiomyopathy (HCM) is characterized
by asymmetrical (septal) hypertrophy in the absence of
increased external load and is caused by mutations in
mainly sarcomeric genes that have an autosomal-domi-
nant pattern of inheritance [1,2]. Several echocardio-
graphic and magnetic resonance studies demonstrated
abnormal left ventricular (LV) systolic and diastolic
function in patients with manifest HCM [3-5]. As the
genetic defect is present from birth, family members of
patients with manifest HCM are at risk to develop
HCM. However, at present, little is known about
changes in cardiac function which precede cardiac
hypertrophy. Identification of abnormalities in cardiac
function before the onset of hypertrophy may provide a
basis for clinical intervention to delay or prevent the
progression to manifest HCM in mutation carriers.
In the healthy heart, myocardial deformation is predo-
minantly based on contraction of helically oriented bun-
dles of myofibers in the endo- and epicardium [6]. A
parameter which directly relates to the functional status
of these bundles of myofibers is LV torsion [7]. Torsion
is described as the overall twisting or ‘wringing’ motion
of the heart caused by an opposite rotation of the base
and apex. Torsional deformation is important during LV
contraction, since it distributes strain homogeneously
over the LV wall [8]. In the absence of torsion, subendo-
cardial fibers would shorten to a greater extent than
subepicardial fibers, leading to non-uniform transmural
fiber shortening. Mathematical models [8] have shown
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that a well balanced interplay between torsion and ejec-
tion volume is necessary to diminish differences between
subendo- and subepicardial fiber contraction. Since LV
ejection is directly dependent on subendocardial circum-
ferential strain (area reduction in the short axis directly
implies shortening of the circumference), the constant
ratios of torsion to subendocardial circumferential strain
(so called torsion-to-shortening ratio (TSR) [9]),
detected in humans and animals with structural normal
hearts, confirm the interplay between LV ejection and
torsion in vivo [9,10]. Changes in this ratio indicate
transmural differences in fiber shortening.
Altered torsion is found to be a sensitive marker for
both systolic and diastolic dysfunction [11-18]. Elevated
torsion and/or TSR-ratios have been detected almost
exclusively in patients with LV hypertrophy caused by
increased hemodynamic loading conditions (i.e. aortic
valve stenosis [11,17] or hypertension [19]), and in
HCM patients [20]. However, elderly with normal LV
wall dimensions also show increased left ventricular tor-
sion, indicating that age-related myocardial alterations
contribute to changes in the pattern of contraction in
this population [12].
Histological studies [21-25] revealed a variety of struc-
tural myocardial abnormalities in manifest HCM (i.e.
myocardial disarray, thickening of the intima layer of
small subendocardial arterioles and areas of fibrosis). As
myocardial architecture might already be altered in pre-
hypertrophied mutation carriers, we hypothesize that
torsion, and hence, the ratio between torsion and suben-
docardial strain, is altered in HCM mutation carriers
with normal wall thickness. In the present study LV tor-
sion was evaluated in mutation carriers and an age and
gender matched control population using cardiovascular
magnetic resonance (CMR).
Methods
Subjects
Seventeen HCM mutation carriers and seventeen age and
gender matched controls without medical history (e.g. no
evidence of other systemic or cardiac disease associated
with LV hypertrophy) were included in the study.
Families of control patients were deprived of sudden car-
diac death and cardiomyopathies. Carriers were first-
degree relatives of HCM index patients and recruited
after genetic testing at the cardiogenetic outpatients’
clinic. They had either a 2373insG mutation in the gene
encoding for cardiac myosin binding protein C
(MYBPC3) [26], or a Glu62Gln missense mutation in the
gene encoding for alpha-tropomyosin (TPM1) [27], as
described previously [28]. All carriers had a LV wall-
thickness <10 mm and showed no signs of LV outflow
tract obstruction, as measured by routine echocardiogra-
phy within one year prior to inclusion. In all participants,
a standard physical examination was executed directly
before CMR acquisition. The study was approved by the
institutional medical ethics committee and conducted
according to the declaration of Helsinki. Written
informed consent was obtained from all participants
before entering the study.
Cardiac magnetic resonance imaging
All subjects were imaged on a 1.5 T whole body scanner
(Magnetom Sonata, Siemens, Erlangen, Germany), using
a six-channel phased-array body coil. All cine studies
were performed in a single breath hold during mild
expiration.
Retro-triggered, balanced steady-state free precession
(SSFP) short-axis cine imaging with full coverage of the
LV was acquired for quantification of LV volumes, mass
and ejection fraction (EF) (Figure 1). Image parameters
were: slice thickness 5 mm, slice gap 5 mm, temporal
resolution <50 ms, 20 phases per cardiac cycle, echo
time 1.54 ms, repetition time 3.2 ms, flip angle 60
degrees and a typical image resolution of 1.3*1.6 mm.
For analysis of left atrial (LA) volume, the same acquisi-
tion was performed in a transversal orientation, planned
on an end-diastolic 2-chamber view at the level of the
Figure 1 CMR techniques used for morphological and
functional assessment. A: End-diastolic basal short-axis SSFP image
of a healthy control, used for quantification of LV volumes and
mass. B: LV basal short-axis end-diastolic HARM-image of the same
patient as (A) with manually drawn epicardial (green) and
endocardial (red) contours. By using Harmonic phase (HARP)
analysis, myocardial deformation can be monitored throughout the
cardiac cycle, allowing determination of left ventricular torsion and
subendocardial circumferential strain (inner 50% of the LV wall)
throughout the cardiac cycle. C: End-diastolic short axis SSFP image
of a HCM mutation carrier, showing normal cardiac morphology
and dimensions. D: LV short axis HARM-image of the same carrier as
(C) acquired at end-systole.
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lower leading edge of the mitral valve annulus as
described previously [29]. The LA was subsequently
fully covered by a stack of transversely oriented slices.
A high temporal resolution (14 ms) 3-chamber cine
image was performed to determine the opening and
closing time of the valves.
In addition, in 15 of the control subjects and in 13 of
the HCM mutation carriers, velocity encoded cine CMR
was applied for quantification of mitral valve inflow
velocities in order to obtain E/A ratios as reflection of
diastolic function. Flow measurements were performed
in a retrospective fast low angle shot (FLASH) phase-
contrast technique with a velocity sensitivity set at 100
cm s-1 [30].
Myocardial tissue tagging (Figure 1) was performed
at three short-axis slices, located at ¼ (base), 1/2
(mid), and ¾ (apex) of the length between the mitral
valve and the apex, planned on an end-systolic four-
chamber image. Sinusoidal, complementary tagged
(CSPAMM) images were acquired with a retro-trig-
gered SSFP sequence using a multiple brief expiration
breath hold scheme [31]. Temporal resolution was 15
ms. The imaging parameters were as follows: field of
view: 300 × 300 mm2, flip-angle: 20°, repetition time:
3.6 ms, echo time: 1.8 ms, receiver bandwidth: 850 Hz/
pixel, matrix size: 256 × 78, slice thickness: 6 mm, tag-
line distance: 7 mm. Acquisition time per slice was
approximately 3-4 minutes. After tagging images were
derived, we administered 0.2 mmol/kg Gadolinium-
DTPA (Magnevist, Schering©) solely to the HCM
mutation carriers, in order to obtain Late Gadolinium
Enhancement (LGE) images for the detection of intra-
myocardial fibrosis.
Post-processing
LV and LA volumes, mass and blood-flow velocities
were analyzed offline, using dedicated software packages
(Mass and Flow, Medis, Leiden, the Netherlands). From
these, volumes, ejection fraction (EF), stroke volume
(SV) and E/A ratio were derived.
From the tagging images, LV torsion was calculated as
the circumferential-longitudinal shear angle using Har-
monic Phase displacement tracking as described before
[32,33]. For this, endo- and epicardial contours were
drawn on the harmonic magnitude (HARM) images
(Figure 1) [34]. Since this method includes the radius
and the length of the ventricle, torsional values are com-
parable between hearts of different sizes. Torsion was
calculated between the basal and apical slices, between
the basal and mid slices and between the mid and apical
slices.
From the torsion curves, peak torsion was derived.
Peak rate of systolic and diastolic torsion was deter-
mined by calculating the time derivative of the torsion
curves, with a temporal resolution of three phases
(45 ms). The peak rates of systolic and diastolic torsion
were corrected for peak torsion, since this parameter
has been shown to increase in proportion to the value
of peak torsion during exercise [35].
Furthermore, Lagrangian circumferential strain was
calculated from the tagging images using the Harmonic
Phase method as described previously [36]. Strains were
assessed for the inner (subendocardial) layer of the myo-
cardium, encompassing 50% of the LV wall. Therefore,
the epicardial contour (green line in Figure 1) was auto-
matically shifted towards the centre of the wall. Peak
values were determined from the strain curves.
Besides, the ratio of peak LV torsion to peak endocar-
dial circumferential shortening (TECS-ratio) was calcu-
lated as an alternative to TSR. We must note that TECS
and TSR are not comparable in absolute terms, since
the calculation of subendocardial circumferential strain
is based upon different definitions (TSR see [10-12,17]).
Statistical analysis
All data are presented as mean ± SD. LA and LV
volumes, LV mass, function, torsion, torsion rates and
circumferential strain were compared between the car-
rier and the control group using Student’s T-test or
Mann-Whitney U test, when appropriate. Torsion was
calculated on different longitudinal levels (base-mid,
mid-apex) and compared within patients using paired
Student’s T-test. Interobserver variability in peak LV
torsion was assessed by redrawing of myocardial con-
tours in 5 randomly selected healthy subjects and car-
riers and recalculating peak torsion by two independent
observers (WPB and IKR). Bland-Altman analysis and
intraclass correlation (ICC) were assessed to determine
agreement. Two-sided p-values < 0.05 were considered
as statistically significant.
Results
Subject characteristics are presented in Table 1. No dif-
ferences in baseline characteristics were observed
between the carriers and the control group. In total,
mutation carriers from 10 different families were
Table 1 Baseline characteristics
Carriers
(n = 17)
Controls
(n = 17)
p-value
Age (years) 40 ± 12 38 ± 13 n.s.
Gender (male/female) 5/12 8/9 n.s.
Systolic blood pressure (mmHg) 115 ± 12 118 ± 7 n.s.
Diastolic blood pressure (mmHg) 66 ± 9 69 ± 7 n.s.
Heart rate (bpm) 63 ± 9 68 ± 8 n.s.
Body surface area (m2) 1.90 ± 0.19 1.90 ± 0.21 n.s.
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included. The majority of carriers (13/17) had a
MYBPC3 mutation, and four had a mutation in the
TPM1 gene.
In Table 2, volumes and function analysis can be
found. The EF was slightly but significantly higher in
carriers (p = 0.04). The LV mass and volumes were
similar in both groups. Furthermore, indices of diastolic
function (E/A ratio, LA volumes and isovolumetric
relaxation time (IVRT)) showed no significant differ-
ences between carriers and controls.
A significant increase in peak base-apex torsion was
found in HCM mutation carriers with respect to con-
trols (p = 0.001) (Table 3, Figure 2), while peak circum-
ferential strain was similar. Hence, TECS-ratio was
significantly increased in the carrier group (Figure 2).
No significant differences could be detected in peak
systolic and diastolic torsion rate, after correction for
peak torsion. This is also shown in Figure 3, which
visually outlines that increased torsion is accompanied
with a similar increment of (uncorrected) torsion rates.
There was no significant difference between torsion
measured at different levels (base-mid, mid-apex) of the
LV (data not shown).
A total of 4 mutation carriers showed small areas of
focal intramyocardial contrast enhancement. In order to
rule out a potential influence of fibrosis on torsional
behaviour and TECS measurements, we compared the
values between LGE positive and LGE negative HCM
mutation carriers. Results showed non-significant differ-
ences between both groups: 9.3 ± 1.85° vs 10.4 ± 2.63°,
p = ns for torsion, and 0.54 ± 0.08°/% vs 0.51 ± 0.16°/%,
p = ns for TECS respectively.
Inter-observer agreement for peak torsion was high,
with an ICC of 0.94 (95% confidence interval: 0.79-0.99),
and limits of agreement are -0.1 ± 16.4% (Figure 4). It
should be noted that inter-observer agreement is only
dependent on drawing of contours, as further calcula-
tion of torsion and its peak value is observer-
independent.
Discussion
Our study demonstrates that HCM mutation carriers
have increased LV torsion in the absence of left ventri-
cular hypertrophy. Most studies evaluating LV rotation
and/or torsion were performed in patients with underly-
ing conditions causing overt (concentric) hypertrophy,
like hypertension or aortic valve stenosis [11,13,17,20].
Increased torsion is generally regarded as the result of
Table 2 LV and LA volumes and function
Carriers
(n = 17)
Controls
(n = 17)
p-value
LV mass (g) 104 ± 26 104 ± 30 n.s.
LV mass/EDV ratio (g/ml) 0.59 ± 0.13 0.57 ± 0.08 n.s.
LV mass/BSA (g/m2) 54.6 ± 11.4 54.4 ± 11.4 n.s.
LVEDV (ml) 177 ± 29 180 ± 35 n.s.
LVESV (ml) 67 ± 12 72 ± 16 n.s.
LV Stroke volume (ml) 111 ± 19 108 ± 20 n.s.
LV Ejection fraction (%) 63 ± 3 60 ± 3 0.04
LAEDV (ml) 49 ± 16 40 ± 9 n.s.
LAESV (ml) 111 ± 30 101 ± 20 n.s.
IVRT (ms) 96 ± 14 92 ± 18 n.s.
E/A ratio 1.62 ± 0.70 1.64 ± 0.61 n.s.
* EDV: end-diastolic volume, ESV: end-systolic volume. Isovolumetric relaxation
time (IVRT); results are mean ± SD; n.s. = non significant.
Table 3 Torsion analysis
Carriers (n = 17) Controls (n = 17) p-value
Peak torsion (°) 10.1 ± 2.5 7.7 ± 1.2 0.001
Peak systolic torsion rate (°/s) 53 ± 15 39 ± 5 0.001
Peak diastolic torsion rate (°/s) -71 ± 17 -54 ± 13 0.003
Peak systolic torsion rate/Peak torsion (s-1) 5.2 ± 1.2 5.2 ± 8.9 n.s.
Peak diastolic torsion rate/Peak torsion (s-1) -7.2 ± 1.7 -7.2 ± 1.8 n.s.
Peak endocardial circumferential strain (%) 19.9 ± 2.8 18.9 ± 2.6 n.s.
TECS-ratio (°/%) 0.52 ± 0.14 0.42 ± 0.10 0.02
Results are mean ± SD; n.s. = non significant.
Figure 2 Error bar plots of Peak LV Torsion (A) and TECS-ratio
(B) (torsion to endocardial circumferential shortening) in the
control and carrier group. The difference between both groups is
significant.
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impaired contraction of predominantly subendocardial
myofibers (due to -relative- hypoperfusion of the thick-
ened wall), leading to diminished counteraction of con-
tracting epicardial fibers, which have a longer lever arm
[8,17].
Remarkably, non-hypertrophied HCM carriers show
similar contraction patterns including a relative increase
in LV torsion with respect to subendocardial circumfer-
ential contraction (e.g. increased TECS-ratio). It was
expected that, due to the elevated ejection fraction in
carriers, torsion and subendocardial circumferential
strain (which is related to ejection volume) values would
show parallel increments, resulting in unaltered TECS-
ratio. Apparently, impairment of subendocardial con-
traction of myofibers changed the balance between tor-
sion and ejection in mutation carriers irrespective of LV
wall thickness.
A variety of disease-related morphological and func-
tional alterations could have attributed to this finding.
Although currently unknown, changes in transmural
distribution and/or angulation of subendocardial myofi-
bers might have influenced regional contraction patterns
in carriers. Besides, perturbations of myocardial perfu-
sion cannot be ruled out, since studies in HCM hearts
revealed abnormalities in small intramural coronary
arteries and subendocardial arterioles [22,23]. A similar
observation of increased LV torsion with unaltered cir-
cumferential strain in asymptomatic Type I Diabetes
Mellitus patients without morphological evidence of car-
diac disease [37], contributes to the idea that intrinsic
disease-related pathology (e.g. small vessel disease was
not ruled out) might be responsible for differences in
myocardial deformation. However, future perfusion stu-
dies are needed to validate this unconfirmed hypothesis.
Except for myocardial disarray and/or disturbed regio-
nal myocardial perfusion as potential explanations for
the relatively impaired subendocardial fiber shortening,
other factors might be affecting LV torsion in HCM
mutation carriers. Interestingly, mutation carriers
showed a (slightly) increased ejection fraction (causing
the difference in TECS to be less pronounced than the
difference in torsion alone (Figure 2)), which is also a
common finding in manifest HCM [38].
This seems in line with the detected rises in systolic
and diastolic torsional rates [35,39,40] under resting
conditions (e.g. normal blood pressure and heart rate),
suggesting that the hearts of carriers are in a hypercon-
tractile state at baseline. On the basis of in vitro studies
with recombinant mutant sarcomeric proteins and
transgenic animal models, it has been proposed that
HCM mutations in sarcomeric proteins cause hypercon-
tractility [41]. Hence, the in vivo changes in cardiac per-
formance in mutation carriers found in the present
Figure 3 Individual, interpolated LV torsion curves for carriers
(red), controls (blue). Individual curves were interpolated to 100
points over their cardiac cycle.
Figure 4 Bland Altman plot of peak torsion values as analyzed by two independent observers. Agreement is similar in healthy subjects
(blue lozenges) and carriers (magenta squares).
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study may be a first indication of altered sarcomeric
function, extrapolated to global functional changes of
the pre-hypertrophied HCM muscle.
Limitations and clinical implications
The number of patients enrolled in the study is limited,
and therefore, results should be interpreted with care.
Nevertheless, the data indicate that significant changes
in LV torsion are present in HCM mutation carriers.
Besides, not all control subjects were genetically
screened for HCM mutations, which theoretically might
have biased results, although prevalence is rather low
for the general population. In addition, since HCM is
associated with an abundance of defects in sarcomeric
genes, findings in carriers with only two types of muta-
tions might not be entirely representative for the general
HCM population.
Finally, we did not perform LGE imaging in healthy
individuals and cannot rule out the presence of fibrosis
in these patients. Nevertheless, the probability to
encounter areas of focal fibrosis in healthy subjects is
very low, and moreover, we demonstrated that the pre-
sence of LGE has little significance on torsional beha-
viour and TECS-values in mutation carriers.
To clarify the meaning and potential clinical implica-
tions of increased torsional values in HCM carriers, we
compared our findings with a group of 10 aged matched
patients (44 ± 8 years) with manifest HCM. As Figure 5
outlines, manifest HCM patients have elevated torsion
and TECS with respect to controls and carriers, with
mean values of 10.6 ± 1.6° and 0.64 ± 0.13°/%, respec-
tively. Carriers have values in between controls and
patients with manifest HCM, indicating that the hearts
of carriers show deformational alterations preceding the
development of hypertrophy. This suggests that the
mutation carriers are in a transitional phase towards
manifest HCM, although future prospective studies are
needed to verify this hypothesis. Early recognition of the
abnormality in LV contraction might imply a closer
monitoring of these patients at different timeframes.
Besides, targeted drug therapy might be applied, aimed
at delaying or preventing wall thickening and associated
symptoms.
Conclusion
This study demonstrates that increased torsional defor-
mation already exists in healthy mutation carriers, even
in the absence of hypertrophy. Although the exact
underlying mechanisms are currently unknown, we
speculate that disease related subendocardial dysfunction
might be responsible for alterations in torsion.
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